Pricing pharmaceutical compounds under development

Trends in Pharmacological Sciences

Volumn 35, Issue 5, 2014, Pages 217-218

  Dimitri, Nicola ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCULATION; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; LETTER; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROBABILITY; PROFIT;

DRUG DESIGN; DRUG DISCOVERY; DRUG INDUSTRY; MODELS, ECONOMETRIC; PHARMACEUTICAL PREPARATIONS;

EID: 84899641729     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2013.12.006     Document Type: Letter

References (4)

1. S. Paul et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge Nat. Rev. Drug Discov. 9 2010 203 214
2. J. Arrowsmith, and P. Miller Trial watch: Phase II and Phase III attrition rates 2011-2013 Nat. Rev. Drug Discov. 12 2013 569
3. N. Dimitri An assessment of R&D productivity in the pharmaceutical industry Trends Pharmacol. Sci. 32 2011 683 685
4. G. Keserij, and G. Makara The influence of lead discovery strategies on the properties of drug candidates Nat. Rev. Drug Discov. 8 2009 203 212